$SHMN:HL:;Going by my -20 yrs in S. Valley... Some of the best Engineers &: Scientists have NO formal degree.... however, this is a MINORITY. Presumably, likewise for financial pros.
My guess is we go through another year with very little progress, there will be some so called progress that doesn’t amount to much but probably not enough to really move the dial. If I am wrong then good for everyone, but history says I am probably right.
"Tony Tontat is an advisor to the Clinova management team on strategic financing plans. He advises the company on long and short term financing.
Tony had been a NASDAQ company CFO and has served as the CFO for multiple private companies during and after their funding rounds ($15M to $250M IPO rounds). Tony has been a healthcare specialist for +20 years, working at the intersection of private companies plotting their path into the public markets.
Tony had been an investment banker at HSBC Investment Bank in their London, New York, and Paris offices. Tony holds an ALB in Economics from Harvard University."
Tony Tontat CFO & COO Kiromic Biopharma inc. "Mr. Tontat has served as our Chief Operating Officer since August 2019, as our Chief Financial Officer since October 2019 and as a member of our board of directors since January 2020. Prior to joining us, Mr. Tontat worked as a business and financial consultant and Financial Analyst since November 2011 for Exuma Blue Advisors, LLC, where he worked with many private and public companies. He primarily helped these companies raise funds at various stages of life cycle. He worked in financial teams to raise funds for public companies like Sorrento Therapeutics, Inc. and NantKwest. Prior to this, he worked as an investment analyst at healthcare- specialist hedge funds in New York and also worked as investment banker at HSBC Investment Bank in their New York and Paris offices.
Mr. Tontat earned his BA in Economics from Harvard University."